YPSOMED HLDG N
YPSOMED HLDG N operates in Diversified Metals & Mining.
YPSOMED HLDG N (OWX) - Total Assets
Latest total assets as of March 2024: €1.10 Billion EUR
Based on the latest financial reports, YPSOMED HLDG N (OWX) holds total assets worth €1.10 Billion EUR as of March 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
YPSOMED HLDG N - Total Assets Trend (2017–2024)
This chart illustrates how YPSOMED HLDG N’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
YPSOMED HLDG N - Asset Composition Analysis
Current Asset Composition (March 2024)
YPSOMED HLDG N's total assets of €1.10 Billion consist of 30.7% current assets and 69.3% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 6.7% |
| Accounts Receivable | €128.03 Million | 11.6% |
| Inventory | €75.29 Million | 6.8% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €281.58 Million | 25.6% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2017–2024)
This chart illustrates how YPSOMED HLDG N's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: YPSOMED HLDG N's current assets represent 30.7% of total assets in 2024, a decrease from 41.6% in 2017.
- Cash Position: Cash and equivalents constituted 6.7% of total assets in 2024, down from 9.2% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 25.0% of total assets, an increase from 17.0% in 2017.
- Asset Diversification: The largest asset category is intangible assets at 25.6% of total assets.
YPSOMED HLDG N Competitors by Total Assets
Key competitors of YPSOMED HLDG N based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MANHATTAN ASSOC
BE:MHT
|
Germany | €698.14 Million |
|
TV BROADCAST
MU:TBCN
|
Germany | €6.25 Billion |
|
FIRST CITIZENS BC A
BE:FC6A
|
Germany | €220.57 Billion |
|
COSTCO WHSL
MU:CTO
|
Germany | €69.83 Billion |
|
GOLDMAN SACHS GROUP - Dusseldorf Stock Exchang
DU:GOS
|
Germany | €1.73 Trillion |
|
BURCKHARDT COMPRE N
MU:B5H
|
Germany | €1.07 Billion |
|
Public Service Company of New Mexico PFD 4.58%
PINK:PNMXO
|
USA | $886.19 Million |
|
2H0
F:2H0
|
Germany | €15.27 Million |
YPSOMED HLDG N - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - YPSOMED HLDG N generates 0.50x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, YPSOMED HLDG N generates $7.12 in net profit.
YPSOMED HLDG N - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.77 | 0.80 | 0.95 |
| Quick Ratio | 0.60 | 0.58 | 0.67 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-102.28 Million | € -50.66 Million | € -9.09 Million |
YPSOMED HLDG N - Advanced Valuation Insights
This section examines the relationship between YPSOMED HLDG N's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 27.8% |
| Total Assets | €1.10 Billion |
| Market Capitalization | $2.88 Million USD |
Valuation Analysis
Below Book Valuation: The market values YPSOMED HLDG N's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: YPSOMED HLDG N's assets grew by 27.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for YPSOMED HLDG N (2017–2024)
The table below shows the annual total assets of YPSOMED HLDG N from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-03-31 | €1.10 Billion | +27.79% |
| 2023-03-31 | €861.88 Million | +13.87% |
| 2022-03-31 | €756.91 Million | +5.47% |
| 2021-03-31 | €717.68 Million | +6.36% |
| 2020-03-31 | €674.74 Million | +14.80% |
| 2019-03-31 | €587.75 Million | +17.49% |
| 2018-03-31 | €500.24 Million | +18.60% |
| 2017-03-31 | €421.80 Million | -- |